{
  "meta": {
    "data_length": 1,
    "message": "Therapy name Elacestrant retrieved successfully",
    "request_url": "http://api.moalmanac.org/therapies?therapy_name=Elacestrant",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.003219,
    "timestamp_received": "2026-04-06T17:41:13.765380+00:00Z",
    "timestamp_returned": "2026-04-06T17:41:13.768599+00:00Z",
    "trace_id": "8a39c226-142b-4756-9a32-4100c2842db4"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-03-05"
  },
  "data": [
    {
      "id": 74,
      "conceptType": "Drug",
      "name": "Elacestrant",
      "primaryCoding": {
        "id": "ncit:C120211",
        "code": "C120211",
        "name": "Elacestrant",
        "system": "https://evsexplore.semantics.cancer.gov",
        "systemVersion": "25.01d",
        "iris": [
          "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C120211"
        ]
      },
      "mappings": [],
      "extensions": [
        {
          "name": "therapy_strategy",
          "value": [
            "ER signaling inhibition"
          ],
          "description": "Associated therapeutic strategy or mechanism of action of the therapy."
        },
        {
          "name": "therapy_type",
          "value": "Hormone therapy",
          "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
        }
      ]
    }
  ]
}